AnX Robotica Announces FDA Clearance for ProScan™: A Groundbreaking AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy
AnX Robotica, a pioneering force in advanced gastrointestinal visualization technologies, is excited to announce the FDA clearance of NaviCam ProScan™. Through the rigorous De Novo Submission Process, the FDA has granted clearance for ProScan, making it the first AI Assisted…
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
Allorion Therapeutics (“Allorion”), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option and global license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and…
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
MediLink Therapeutics (“MediLink”), announced today that it has entered into a worldwide collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) on the development of a next-generation antibody-drug conjugate candidate YL211, targeting c-Mesenchymal epithelial transition factor (c-Met) against solid tumors. Under…
Health Net Federal Services Earns Distinction with Renewed URAC Accreditations
Health Net Federal Services, LLC (HNFS), a Centene Corporation (NYSE: CNC) subsidiary, announced its renewed Utilization Review Accreditation Commission (URAC) accreditations in Health Network, Health Utilization Management, Case Management, and Disease Management. This achievement underscores HNFS’s ongoing commitment to quality care, enhanced processes, patient safety, and…
